Literature DB >> 33140190

In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.

Maryam Moradi-Chaleshtori1, Mojgan Bandehpour2, Sara Soudi3, Samira Mohammadi-Yeganeh4,5, Seyed Mahmoud Hashemi6,7.   

Abstract

In the tumor microenvironment, macrophages polarize into the M2 phenotype to facilitate tumorigenesis. Tumor-derived exosomes can act as mediators between the tumor microenvironment and stromal cells by transporting proteins, mRNAs, and miRNAs. Exosomal miRNAs play a pivotal role in modulating tumor microenvironment and macrophage polarization. Here, we overexpressed miR-130 and miR-33 in exosomes of MDA-MB-231 cells and investigated their effect on macrophage polarization and tumor progression. For this purpose, exosomes were extracted from MDA-MB-231 cells and characterized using dynamic light scattering, electron microscopy, and western blotting of exosomal markers. Then, miR-130 or miR-33 containing exosomes were used to treat IL4-induced M2 or tumor-associated macrophages (TAMs). After treatment, the polarization status of macrophages, including the expression of M1 specific genes, and the secretion of cytokines were evaluated. Finally, the conditioned medium from exosome-treated macrophages was incubated with cancer cells to evaluate its effect on the migration and invasion ability of cancer cells and, in vivo experiments investigated the effect of exosome-treated macrophages on breast cancer progression. Exosomes characterization results approved the range of size and homogeneity of extracted exosomes. Overexpression of miR-130 and miR-33 in exosomes increased the expression of M1 signature genes (IRF5, MCP1, CD80) and secretion of cytokines (IL-1β and TNF-α) as well as yeast phagocytic activity of macrophages. Besides, the conditioned medium of macrophages treated with miRNA containing exosomes declined the migration and invasion ability of cancer cells. The in vivo results indicated the inhibitory effect of exosome-treated macrophages on tumor growth. Furthermore, the results showed that in response to exosome-treated macrophages, the production of TNF-α by spleen cells increased, while the production of IL-10 and TGF-β by these cells decreased. These findings suggest that overexpression of miR-130 and miR-33 in exosomes can decrease tumor progression by shifting macrophage polarization from M2 to M1 phenotype and can be a potential therapeutic strategy for tumor interventions.

Entities:  

Keywords:  Breast cancer; Exosome; Macrophage polarization; Tumor-associated macrophage; miRNA

Mesh:

Substances:

Year:  2020        PMID: 33140190     DOI: 10.1007/s00262-020-02762-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  2 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization.

Authors:  M Trivedi; M Talekar; P Shah; Q Ouyang; M Amiji
Journal:  Oncogenesis       Date:  2016-08-08       Impact factor: 7.485

  2 in total
  9 in total

Review 1.  Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.

Authors:  Wenhao Li; Xiaolong Wang; Chen Li; Tong Chen; Qifeng Yang
Journal:  Mol Ther       Date:  2021-12-02       Impact factor: 11.454

Review 2.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

Review 3.  Exosome-Based Nanoplatforms: The Emerging Tools for Breast Cancer Therapy.

Authors:  Quan Liu; Xian Zhang; Jun Zhang
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

Review 4.  Targeting tumor-associated macrophages for cancer treatment.

Authors:  Mengjun Li; Linye He; Jing Zhu; Peng Zhang; Shufang Liang
Journal:  Cell Biosci       Date:  2022-06-07       Impact factor: 9.584

Review 5.  The Immuno-Modulation Effect of Macrophage-Derived Extracellular Vesicles in Chronic Inflammatory Diseases.

Authors:  Yi Xing; Xun Sun; Yiming Dou; Min Wang; Yanmei Zhao; Qiang Yang; Yanhong Zhao
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

Review 6.  Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.

Authors:  Ohanes Ashekyan; Samira Abdallah; Ayman Al Shoukari; Ghada Chamandi; Hayat Choubassy; Abdul Rahman S Itani; Nisreen Alwan; Rihab Nasr
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

Review 7.  OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.

Authors:  Khalid Otmani; Redouane Rouas; Philippe Lewalle
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

Review 8.  The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.

Authors:  Yanghong Ni; Xiaoting Zhou; Jia Yang; Houhui Shi; Hongyi Li; Xia Zhao; Xuelei Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-20

Review 9.  Endometriosis and Cancer: Exploring the Role of Macrophages.

Authors:  Daria Artemova; Polina Vishnyakova; Elena Khashchenko; Andrey Elchaninov; Gennady Sukhikh; Timur Fatkhudinov
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.